{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Lower Extremity Lymphedema Presence in Female Cancer Survivors

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify a risk factor for and a risk from lymphedema.
  2. Explain the results and recommendations from the CALGB70305 and the Women's Health Initiative Life and Longevity After Cancer (LILAC) studies.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of the incidence of lower extremity lymphedema in female cancer survivors by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH
  • NM - BON 1.0 CH
  • SC - BON 1.0 CH
  • WV - BOERN 1.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: OT0622
Published: June 2022
Expires: 6/6/2025
Sources: Oncology Times
Required Passing Score: 8/10 (80%)
Authors: Lindsey Nolen